Albert L. Lord - 18 Dec 2015 Form 4 Insider Report for AppTech Payments Corp. (APCX)

Role
Director
Signature
/s/ Albert L. Lord
Issuer symbol
APCX
Transactions as of
18 Dec 2015
Net transactions value
+$1,969,899
Form type
4
Filing time
05 Feb 2025, 20:05:36 UTC
Next filing
10 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APCX Common Stock Award $1.9 +2 $0.9500 2 18 Dec 2015 By Trusts F1
transaction APCX Common Stock Award $150,000 +105,263 +5263150% $1.42 105,265 28 Dec 2015 By Trusts F1
transaction APCX Common Stock Award $9,999 +13,157 +12% $0.7600 118,422 26 May 2016 By Trusts F1
transaction APCX Common Stock Award $59,998 +31,578 +27% $1.90 150,000 23 Feb 2021 By Trusts F1
transaction APCX Common Stock Award $249,900 +300,000 +200% $0.8330 450,000 04 Feb 2025 By Trust F2, F3, F8
transaction APCX Common Stock Award $1,000,000 +1,000,000 +222% $1.00 1,450,000 04 Feb 2025 By Trust F3, F4, F10
transaction APCX Common Stock Award $500,000 +500,000 +34% $1.00 1,950,000 04 Feb 2025 By Fund F5, F6, F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APCX Firm Warrant 4 Award +300,000 300,000 04 Feb 2025 Common Stock 300,000 $0.9000 By Trust F7, F8, F9
transaction APCX Firm Warrant 5 Award +450,000 +150% 750,000 04 Feb 2025 Common Stock 450,000 $1.20 By Trust F7, F8, F9
transaction APCX Firm Warrant 6 Award +1,000,000 +133% 1,750,000 04 Feb 2025 Common Stock 1,000,000 $0.9000 By Trust F9, F10, F11
transaction APCX Firm Warrant 6 Award +500,000 +29% 2,250,000 04 Feb 2025 Common Stock 500,000 $0.9000 By Fund F11, F12, F13
transaction APCX Firm Warrant 7 Award +1,500,000 +67% 3,750,000 04 Feb 2025 Common Stock 1,500,000 $1.20 By Trust F9, F10, F11
transaction APCX Firm Warrant 7 Award +750,000 +20% 4,500,000 04 Feb 2025 Common Stock 750,000 $1.20 By Fund F11, F12, F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Albert L. Lord Jr. Revocable Trust dated May 10, 2017, & the Suzanne D. Lord Revocable Trust dated May 10, 2017. Mr. Lord claims beneficial ownership of such shares and is the trustee for both trusts.
F2 Shares were transferred by AFIOS Partners 6 to the Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust.
F3 The Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust dated January 17, 2025. Mr. Lord claims beneficial ownership of such shares and is the trustee.
F4 Shares were transferred by AFIOS Partners 7 to the Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust.
F5 Shares were transferred by AFIOS Partners 7 to the Starfish Fund.
F6 The Starfish Fund dated July 2, 2007. Mr. Lord claims beneficial ownership of such shares and is the President.
F7 Warrants were transferred by AFIOS Partners 6 to the Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust.
F8 Warrants were issued in conjunction with direct investment to the Company, where each $0.833 investment resulted in the issuance of one share of common stock, one warrant exercisable at $0.90, and one hundred fifty percent additional warrant coverage exercisable at $1.20.
F9 The Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust dated January 17, 2025. Mr. Lord claims beneficial ownership of such warrants and is the trustee.
F10 Warrants were transferred by AFIOS Partners 7 to the Albert L. Lord, Jr. 2025 Spousal Estate Reduction Trust.
F11 Warrants were issued in conjunction with direct investment to the Company, where each $1.00 investment resulted in the issuance of one share of common stock, one warrant exercisable at $0.90, and one hundred fifty percent additional warrant coverage exercisable at $1.20.
F12 Warrants were transferred by AFIOS Partners 7 to the Starfish Fund.
F13 The Starfish Fund dated July 2, 2007. Mr. Lord claims beneficial ownership of such warrants and is the President.